Education
About Us
Working with TipRanks
Follow Us
Canopy Growth (CGC)
NASDAQ:CGC
CGC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.77 - $7.21
Previous Close$2.65
Volume6.63M
Average Volume (3M)14.73M
Market Cap
$354.32M
Enterprise Value$494.73M
Total Cash (Recent Filing)$131.47M
Total Debt (Recent Filing)$348.40M
Price to Earnings (P/E)―
Beta2.12
Next Earnings
Nov 07, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding201,362,550
10 Day Avg. Volume24,415,606
30 Day Avg. Volume14,729,494
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.40
Enterprise Value/Revenue1.84
Enterprise Value/Gross Profit6.22
Enterprise Value/Ebitda-1.03
Forecast
1Y Price Target
$2.80Price Target Upside87.92% Upside
Rating ConsensusHold
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Cost ReductionManagement has identified new cost-reduction plans that are expected to lead to cost savings of at least C$20mn over the next 12-18 months.
Bears Say
Market ConditionsFactors weighing on Canopy’s stock include gross margin inconsistency, a challenging adult use market in Canada, new rules for Poland’s medical category, high operational costs and lack of federal reform.
Operational ChallengesCanopy has lingering execution problems, such as reliable product supply, resource allocation, supply chain coordination, and poor alignment between consumer demand and products sold.
Regulatory PressureRecent regulatory changes in Poland are putting near-term pressure on its international operations.
Stock PerformanceCanopy's stock price has plunged significantly due to its two recent ATM programs to raise cash and other unfavorable factors.
Canopy Growth News
CGC FAQ
What was Canopy Growth’s price range in the past 12 months?
Canopy Growth lowest stock price was $0.77 and its highest was $7.21 in the past 12 months.
What is Canopy Growth’s market cap?
Canopy Growth’s market cap is $354.32M.
When is Canopy Growth’s upcoming earnings report date?
Canopy Growth’s upcoming earnings report date is Nov 07, 2025 which is in 83 days.
How were Canopy Growth’s earnings last quarter?
Canopy Growth released its earnings results on Aug 08, 2025. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.168 by $0.008.
Is Canopy Growth overvalued?
According to Wall Street analysts Canopy Growth’s price is currently Undervalued.
Does Canopy Growth pay dividends?
Canopy Growth does not currently pay dividends.
What is Canopy Growth’s EPS estimate?
Canopy Growth’s EPS estimate is -0.12.
How many shares outstanding does Canopy Growth have?
Canopy Growth has 201,362,550 shares outstanding.
What happened to Canopy Growth’s price movement after its last earnings report?
Canopy Growth reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.168. Following the earnings report the stock price went up 19.048%.
Which hedge fund is a major shareholder of Canopy Growth?
Currently, no hedge funds are holding shares in CGC
Canopy Growth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.80 (87.92% Upside)
$2.80 (87.92% Upside)
Blogger Sentiment
Bearish
CGC Sentiment 75%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $76.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.88%
12-Months-Change
Fundamentals
Return on Equity
-98.42%
Trailing 12-Months
Asset Growth
-29.47%
Trailing 12-Months
Company Description
Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
CGC Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected significant top-line growth in cannabis revenue, successful cost reduction initiatives, and improved cash flow. However, these positive outcomes were tempered by challenges in certain segments like Storz & Bickel, compressed margins, and specific international market challenges, resulting in a slightly mixed picture.View all CGC earnings summariesCGC Stock 12 Month Forecast
Average Price Target
$2.80
▲(87.92% Upside)
Technical Analysis
Aurora Cannabis
―
Cronos Group
―
Curaleaf Holdings
―
Green Thumb Industries
―
Trulieve Cannabis
―
Ownership Overview
1.34% Insiders
0.01% Mutual Funds
0.07% Other Institutional Investors
94.91% Public Companies and Individual Investors